The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
A Prospective, Randomized Trial of the Effect of Buprenorphine Continuation Versus Dose Reduction on Pain Control and Post-Operative Opioid Use
Sponsor: MaineHealth
Terminated
This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.
Other terminated trials from MaineHealth
Other Opioid-use Disorder trials with similar outcome
A PHASE4 clinical study on Opioid-use Disorder, this trial is terminated or withdrawn. The trial is conducted by MaineHealth and has accumulated 8 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Jan 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2024 — Jul 2024 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Dec 2022 — Jan 2024 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
May 2022 — Dec 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — May 2022 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MaineHealth
- National Institute of General Medical Sciences (NIGMS)
For direct contact, visit the study record on ClinicalTrials.gov .